抗肿瘤药物的基因导向性个体化治疗

被引：38

作者：

周宏灏

刘洁

机构：

[1] 中南大学临床药理研究所

来源：

肿瘤药学 | 2011年 / 1卷 / 01期

关键词：

抗肿瘤药物; 基因导向; 个体化;

D O I：

暂无

中图分类号：

R979.1 [抗肿瘤、抗癌药物];

学科分类号：

1007 ;

摘要：

遗传药理学与药物基因组学的发展对于开展肿瘤的个体化治疗具有非常重要的意义。药物基因组学的发展使得多种影响肿瘤药物的遗传变异得以阐明,并进一步影响肿瘤治疗过程中的新药研发与个体化治疗。本文针对目前明确的能够影响抗肿瘤药物疗效的常见遗传变异进行综述,以促进抗肿瘤药物个体化治疗模式的推广。

引用

页码：6 / 11

页数：6

共 6 条

[1] A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation [J].

Terrazzino, Salvatore ;

Agostini, Marco ;

Pucciarelli, Salvatore ;

Pasetto, Lara Maria ;

Friso, Maria Luisa ;

Ambrosi, Alessandro ;

Lisi, Veronica ;

Leon, Alberta ;

Lise, Mario ;

Nitti, Donato .

PHARMACOGENETICS AND GENOMICS, 2006, 16 (11) :817-824

[2] Association of ABCB1 genotypes with paclitaxel-mediated peripheral neuropathy and neutropenia [J].

Sissung, Tristan M. ;

Mross, Klaus ;

Steinberg, Seth M. ;

Behringer, Dirk ;

Figg, William D. ;

Sparreboom, Alex ;

Mielke, Stephan .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (17) :2893-2896

[3]

Pharmacogenetics of irinotecan: A promoter polymorphism of UGT1A1 gene and severe adverse reactions to irinotecan[J] . Maki Ando,Yoshinori Hasegawa,Yuichi Ando.Investigational New Drugs . 2005 (6)

[4]

A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer .2 Stoehlmacher J,Ghaderi V,Iobal S,et al. Anticancer Res . 2001

[5]

MDR-1single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy .2 H Green,P Soderkvist,P Rosenberg,G Horvath,C Peterson. Clin Cancer Res . 2006

[6]

Pharmacogenetics of thiopurine S-methyltransferase and thiopurine therapy .2 Evans,W. E. Ther. Drug Monit . 2004

← 1 →